Literature DB >> 1580328

Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients.

A P Dalmasso1, G M Vercellotti, R J Fischel, R M Bolman, F H Bach, J L Platt.   

Abstract

The authors investigated the importance of natural antibody and complement in the pathogenesis of hyperacute xenograft rejection using in vivo and in vitro pig to primate models. Studies were carried out in rhesus monkeys transplanted with a pig heart or kidney in which hyperacute rejection was observed within a few hours. The rejected organs showed deposits of IgM, C3, C4, C5, and C9 neoantigen along small blood vessels, but few deposits of factors B and P. Removal of anti-endothelial cell "natural" antibodies by plasmapheresis, immunoabsorption, and immunosuppression techniques resulted in marked prolongation of the survival of a subsequently transplanted heart, even when complement levels were within the normal range. Thus, complement, in the absence of natural antibodies, did not initiate hyperacute rejection in this species combination. The requirements for complement activation in human serum to cause cytotoxicity of porcine endothelial cells were then evaluated. Cytotoxicity was abrogated by depleting human serum of IgM, C2, or C5, but not of factor B. Restoration of the effect of serum on endothelial cells was achieved by reconstitution of the respective depleted sera with purified IgM or with the corresponding complement proteins, indicating that IgM and the classical, but not the alternative, pathway of complement, were involved. Identical conclusions were drawn from experiments to ascertain the requirements for complement activation in human serum to mediate binding of iC3b to porcine endothelial cells. The authors conclude that in a pig to primate xenograft complement does not directly initiate injury to the graft but rather requires activation by bound xenoreactive natural antibodies; IgM antibodies directed against endothelial cells activate the classical complement pathway, which then contributes to endothelial cell activation and subsequent events characteristic of hyperacute rejection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1580328      PMCID: PMC1886521     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

1.  Prolongation of survival of discordant kidney xenografts by C6 deficiency.

Authors:  X J Zhow; N Niesen; I Pawlowski; G Biesecker; G Andres; J Brentjens; F Milgram
Journal:  Transplantation       Date:  1990-11       Impact factor: 4.939

Review 2.  The regulators of complement activation (RCA) gene cluster.

Authors:  D Hourcade; V M Holers; J P Atkinson
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

3.  Immunopathology of hyperacute xenograft rejection in a swine-to-primate model.

Authors:  J L Platt; R J Fischel; A J Matas; S A Reif; R M Bolman; F H Bach
Journal:  Transplantation       Date:  1991-08       Impact factor: 4.939

4.  Neutrophil adhesion to xenogeneic endothelium via iC3b.

Authors:  G M Vercellotti; J L Platt; F H Bach; A P Dalmasso
Journal:  J Immunol       Date:  1991-01-15       Impact factor: 5.422

5.  Hyperacute rejection of xenografts in the complete absence of antibody.

Authors:  P S Johnston; S M Lim; M W Wang; L Wright; D J White
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

6.  Prolonged survival of a discordant cardiac xenograft in a rhesus monkey.

Authors:  R J Fischel; J L Platt; A J Matas; E Perry; A P Dalmasso; C Manivel; J S Najarian; F H Bach; R M Bolman
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

7.  Renal xenograft rejection: prolonging effect of captopril, ACE-inhibitors, prostacyclin, and cobra venom factor.

Authors:  E Kemp; D Steinbrüchel; H Starklint; S Larsen; I Henriksen; H Dieperink
Journal:  Transplant Proc       Date:  1987-12       Impact factor: 1.066

8.  Clq: rapid purification method for preparation of monospecific antisera and for biochemical studies.

Authors:  K Yonemasu; R M Stroud
Journal:  J Immunol       Date:  1971-02       Impact factor: 5.422

9.  Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor. Potential for prevention of xenograft hyperacute rejection.

Authors:  A P Dalmasso; G M Vercellotti; J L Platt; F H Bach
Journal:  Transplantation       Date:  1991-09       Impact factor: 4.939

Review 10.  Complement in the pathophysiology and diagnosis of human diseases.

Authors:  A P Dalmasso
Journal:  Crit Rev Clin Lab Sci       Date:  1986       Impact factor: 6.250

View more
  26 in total

1.  Reduction in the level of Gal(alpha1,3)Gal in transgenic mice and pigs by the expression of an alpha(1,2)fucosyltransferase.

Authors:  A Sharma; J Okabe; P Birch; S B McClellan; M J Martin; J L Platt; J S Logan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

Review 2.  Accommodation of grafts: implications for health and disease.

Authors:  Amy H Tang; Jeffrey L Platt
Journal:  Hum Immunol       Date:  2007-05-15       Impact factor: 2.850

Review 3.  Recent advances in the immunology of xenotransplantation.

Authors:  T Takahashi; S Saadi; J L Platt
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

4.  Immune complex formation after xenotransplantation : evidence of type III as well as type II immune reactions provide clues to pathophysiology.

Authors:  Z E Holzknecht; S Coombes; B A Blocher; T B Plummer; M Bustos; C L Lau; R D Davis; J L Platt
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

5.  Current status of animal-to-human transplantation.

Authors:  Robert Zhong; Jeffrey L Platt
Journal:  Expert Opin Biol Ther       Date:  2005-11       Impact factor: 4.388

Review 6.  The complex functioning of the complement system in xenotransplantation.

Authors:  Hongmin Zhou; Hidetaka Hara; David K C Cooper
Journal:  Xenotransplantation       Date:  2019-04-29       Impact factor: 3.907

7.  Pig complement regulator factor H: molecular cloning and functional characterization.

Authors:  Guido A Hegasy; Ute Willhoeft; Sandra A Majno; Harald Seeberger; Peter F Zipfel; Jens Hellwage
Journal:  Immunogenetics       Date:  2003-09-27       Impact factor: 2.846

8.  Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation.

Authors:  J C Magee; B H Collins; R C Harland; B J Lindman; R R Bollinger; M M Frank; J L Platt
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

9.  Fulminant second-set allograft rejection and endoscopic findings following small bowel transplantation in the rat.

Authors:  N Toyama; E Kobayashi; S Yamada; S Enosawa; M Miyata
Journal:  J Gastroenterol       Date:  1995-08       Impact factor: 7.527

Review 10.  The role of antibodies in transplantation.

Authors:  Alexander T Chang; Jeffrey L Platt
Journal:  Transplant Rev (Orlando)       Date:  2009-07-22       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.